Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02933541 · ClinicalTrials.gov registry record
Central Arterial Pressure Changes With Use of Regional Anesthesia in Obstetric Patients
A clinical trial, sponsored by St. Louis University.
- Completed
- Registry status
- 12
- Enrollment target
NCT02933541: Completed study, sponsored by St. Louis University.
NCT02933541 is a clinical trial that has completed, run by St. Louis University. The registered enrollment target is 12 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02933541 has completed, sponsored by St. Louis University.
- COMPLETED
- Registry status
- 12 participants
- Enrollment target
Study Summary
Plan to monitor central arterial pressure in women who are undergoing spinal anesthesia for cesarean delivery or epidural anesthesia for vaginal delivery.
Primary Outcome
To determine if women who are obese undergo a larger change in their central arterial pressure than is seen by routine brachial cuff assessment, and if this effect is dependent on the level of obesity.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2016-09 |
| Est. Completion | 2023-10-19 |
What the finished NCT02933541 record still lists
NCT02933541 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 12 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT02933541 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02933541 about?
NCT02933541 is a clinical study titled "Central Arterial Pressure Changes With Use of Regional Anesthesia in Obstetric Patients". Plan to monitor central arterial pressure in women who are undergoing spinal anesthesia for cesarean delivery or epidural anesthesia for vaginal delivery.
What is the current status of trial NCT02933541?
This trial is currently completed. The enrollment target is 12 participants. The study started on 2016-09. Estimated completion is 2023-10-19.
Who is sponsoring clinical trial NCT02933541?
This trial is sponsored by St. Louis University, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02602769 · 12 participants
Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome
- NCT02605421 · 12 participants · Phase 2
Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma
- NCT02619448 · 12 participants · Early Phase 1
Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC
- NCT03311503 · 12 participants · Phase 1
Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia